Quantcast
Last updated on April 21, 2014 at 9:29 EDT

Latest Macular degeneration Stories

Eye Gene Therapy
2014-01-16 09:44:41

Brett Smith for redOrbit.com - Your Universe Online A newly developed genetic therapy for treating a type of inherited blindness called choroideremia is showing some promise and allowing patients to see incrementally more than they had before the treatment, according to a new report in The Lancet. Six patients in the study had one eye treated with the gene therapy in operations at the Oxford Eye Hospital in the United Kingdom. After six months, the treated eye showed improved vision in...

2014-01-13 16:26:26

GENEVA, Jan. 13, 2014 /PRNewswire/ -- Selexis SA, a serial innovation company focused on drug discovery for lead identification and cell line development for scale-up and manufacturing of therapeutic protein drugs announced today that Opthea Pty Ltd has entered into a commercial license agreement with Selexis covering the use of the CHO-M Cell Line and related technologies for the production of OPT-302 (formerly VGX-300), an Fc fusion protein for the treatment of wet Age-Related...

2014-01-09 00:21:38

Report Examines the Impact of Digital Media on Vision Health ALEXANDRIA, Va., Jan. 9, 2014 /PRNewswire/ -- A report released today at the 2014 Consumer Electronics Show by The Vision Council finds that nearly 70 percent of U.S. adults experience digital eye strain while on digital devices - including computers, tablets and smartphones. Yet, about half of adults don't know how to or have never tried to reduce their visual discomfort. As the market experiences a surge in high technology-related...

Scientists Use Drug To Repair Rare Birth Defect
2013-12-22 17:37:52

University of British Columbia Success in mouse model is first instance of drug reversing a congenital deformity University of British Columbia and Vancouver Coastal Health scientists have developed a potential cure for a rare eye disease, showing for the first time that a drug can repair a birth defect. They formulated the drug Ataluren into eye drops, and found that it consistently restored normal vision in mice who had aniridia (ANN-uh-ridee- uh), a condition that severely limits...

2013-12-18 23:01:23

Low Vision optometrist and nutritionist John M. Pino O.D., Ph.D., the only International Academy of Low Vision Specialists (IALVS) doctor in Tennessee, holds a doctorate in nutrition. Dr. Pino concurs with a study in the American Journal of Clinical Nutrition suggesting that taking certain B vitamins may prevent Age Related Macular Degeneration (AMD). Lebanon, Tennessee (PRWEB) December 18, 2013 While it’s normal for eyesight to decline over the years, some of the leading causes of...

2013-12-18 08:28:42

TARRYTOWN, N.Y., Dec. 18, 2013 /PRNewswire/ -- Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Administration (FDA) has accepted for standard review the Company's supplemental Biologics License Application (sBLA) for EYLEA(®) (aflibercept) Injection for the treatment of Diabetic Macular Edema (DME). Under the Prescription Drug User Fee Act (PDUFA), the goal for a standard review of an sBLA is ten months from submission, for a target action...

2013-12-12 23:31:21

Two events at the American Academy of Ophthalmology Meeting (AAO) highlighted the importance of visual evoked potential (VEP) and pattern electroretinography (ERG) being used in the clinical assessment of ophthalmology patients. Pine Brook, NJ (PRWEB) December 12, 2013 Doctors Farrell Tyson, MD and Mark Latina, MD led two important discussions on office-based electrophysiology at this year’s American Academy of Ophthalmology Meeting (AAO) in New Orleans. Attendees crowded into the...

Astronauts Diagnosed With Eye Problems After Returning From Space
2013-12-11 16:34:15

NASA Those who travel to space are rewarded with a beautiful sight – planet Earth. But the effects of space travel on the human sense of sight aren’t so beautiful. More than 30 percent of astronauts who returned from two-week space shuttle missions and 60 percent who spent six months aboard the International Space Station were diagnosed with eye problems. Two recent investigations examined mechanisms that may explain eye changes in spaceflight, help find ways to minimize this health...

2013-12-06 12:25:09

GRK Partners Chairman Gary Katcher Motivated to Find Sight-Saving Treatments and Cures COLUMBIA, Md., Dec. 6, 2013 /PRNewswire-iReach/ -- The Foundation Fighting Blindness, a nonprofit dedicated to finding preventions, treatments and cures for vision-robbing retinal degenerative diseases, has appointed Gary Katcher of Greenwich, CT as a National Trustee of the organization. The new role recognizes his ongoing support of FFB's urgent mission to drive cutting-edge research to help the...

2013-12-06 08:24:48

LOS ANGELES, Dec. 6, 2013 /PRNewswire/ -- Los Angeles optometrist, Dr. Ramin Rabbani, is now offering iVitamins, which can help patients achieve optimal eye health. Ocular nutritional therapy combines leading-edge technology with natural supplements to create solutions for some of the most common eye health problems. iVitamins from EyeScience feature complete formulas that are based on the most advanced nutritional research. About Dr. Ramin Rabbani, Eye Doctor Los Angeles Dr....